Case reports: CD20 positive T-cell lymphoma/leukemia: A rare entity with potential diagnostic pitfalls

Annals of Clinical and Laboratory Science

Volumn 37, Issue 3, 2007, Pages 263-267

  Buckner, Carl L ^a   Christiansen, Lydia R ^a   Bourgeois, Danyel ^a   Lazarchick, John J ^a   Lazarchick, John ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

CD20 antigen; Leukemia; Lymphoma; Rituximab

Indexed keywords

CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; HUMAN; IMMUNOPHENOTYPING; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTE DIFFERENTIATION; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SPLENOMEGALY; T CELL LYMPHOMA; CANCER STAGING; DIFFERENTIAL DIAGNOSIS; FATALITY; FLOW CYTOMETRY; IMMUNOLOGY; MIDDLE AGED;

AGED, 80 AND OVER; ANTIGENS, CD20; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MIDDLE AGED; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 34548169821     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Anon. World Health Organization Classification of Tumours: Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2001.
2. Mohrmann RL, Arber DA. CD20 positive peripheral T cell lymphoma: report of a case after nodular sclerosis Hodgkin's disease and review of the literature. Mod Pathol 2000;13:1244-1252.
3. Sun T, Akalin A, Rodacker M, Braun T. CD20 positive T cell lymphoma: is it a real entity? J Clin Pathol 2004;57:442-444.
4. Kitamura A, Yamashita Y, Mori N. CD20-positive cytotoxic T cell lymphoma: report of two cases and review of the literature. J Clin Exp Hematopathol 2005;45:45-50.
5. Quintanilla-Martinez L, Preffer F, Rubin D, Ferry J, Harris N. CD20+ T cell lymphoma, neoplastic transformation of a normal T cell subset. Am J Clin Pathol 1994;102:483-489.
6. Yokose N, Ogata K, Sugisaki Y, Mori S, Yamada T, An E, Dan K. CD20-positive T cell leukemia/lymphoma: case report and review of the literature. Ann Hematol 2001;80:372-375.
7. Takami A, Saito M, Nakao S, Asakura H, Nozue T, Onoe Y, Yachie A, Shiobara S, Matsuda T. CD20-positive T cell chronic lymphocytic leukemia. Fr J Haematol 1998;102:1327-1329.
8. Yao X, Teruya-Feldstein J, Raffeld M, Sorbara L. Peripheral T cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall. Mod Pathol 2001;14:105-110.
9. Magro C, Seilstad K, Porcu P, Morrison C. Primary CD20+CD10+CD8+ T cell lymphoma of the skin with dual IgH and TCRB gene rearrangement. Am J Clin Pathol 2006;126:14-22.
10. Blakolmer K, Vesely M, Kummer JA, Jurecka W, Mannhalter C, Chott A. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T-(NK/T-) cell lymphomas. Mod Pathol 2000;13:766-772.
11. Hultin L, Hausner M, Hultin P, Giorgi J. CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes. Cytometry 1993;14:196-204.
12. Algino KM, Thomason RW, King DE, Montiel MM, Craig FE. CD20 (pan-B cell antigen) expression on bone marrow-derived T cells. Am J Clin Pathol 1996;106:78-81.